Paradigm Biopharmaceuticals Ltd.ASX: PAR

S&P DJI Announces March 2022 Quarterly Rebalance

Mar 4, 2022 at 11:22 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment